drugset / Trial / NCT05708690

Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery

NCT05708690 ↗

Phase 4 Completed 132 enrolled Indonesia University
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a single-center, double-blind, randomized controlled trial (RCT) comparing two groups of application of topical dose of tranexamic acid (TxA) versus placebo in patients undergoing coronary artery bypass graft (CABG), off pump coronary bypass graft cardiac surgery (OPCAB), and adult heart valve surgery. The primary outcomes of this study comprised of two parameters; post operative bleeding and blood product transfusion. The primary outcomes were assessed during the operation, until 48-hour post operative.

Timeline

Start
2022-10-01
Primary completion
2022-12-31
Completion
2023-01-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 5 g Topical